Han Tian, Zheng Ke, Chen Yingjun, Gao Yang, He Li, Zhou Xingtao
Department of Ophthalmology and Vision Science, Eye and ENT Hospital of Fudan University, No.19 Baoqing Road, Xuhui District, Shanghai, China.
Aier School of Ophthalmology, Central South University, Changsha, China.
BMC Ophthalmol. 2016 Aug 30;16(1):149. doi: 10.1186/s12886-016-0331-0.
To investigate long-term refractive outcomes, wavefront aberrations and quality of life after small incision lenticule extraction (SMILE) for moderate to high myopia.
A total of 26 patients (47 eyes) with preoperative mean spherical equivalent (SE) of -6.30 ± 1.47 diopters (D) who underwent SMILE were recruited. The measurements included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction, wavefront aberrations, and quality of life.
At 4 years postoperatively, UDVA was better than or equal to 20/20 in 92 % of eyes. The efficacy index was 1.07 ± 0.16. 89 % of eyes were within ± 0.5 D of the intended refractive target. No eye lost any Snellen lines. The safety index was 1.16 ± 0.14. No significant changes of SE occurred among postoperative follow-ups at months 1, 3, 6 and years 1, 2, 4 (P > 0.05, Scheffe test). Higher-order aberrations, coma, spherical aberration and higher-order astigmatism increased postoperatively, and no significant changes of aberrations were detected among the 1-month, 6-month or 4-year follow-ups postoperatively (37 eyes). Compared to the spectacles group, the surgery group showed a significantly higher total score on quality of life (45.71 ± 2.61 vs 39.96 ± 3.56, P < 0.001).
SMILE provides a predictable and stable correction of moderate to high myopia as documented by long-term follow-up.
探讨中高度近视患者行小切口透镜切除术(SMILE)后的长期屈光效果、波前像差及生活质量。
招募26例患者(47只眼),术前平均球镜等效度(SE)为-6.30±1.47屈光度(D),均接受SMILE手术。测量指标包括裸眼远视力(UDVA)、矫正远视力(CDVA)、显验光、波前像差和生活质量。
术后4年,92%的患眼UDVA优于或等于20/20。有效指数为1.07±0.16。89%的患眼屈光度数在预期目标±0.5D范围内。无患眼视力下降。安全指数为1.16±0.14。术后1、3、6个月及1、2、4年随访期间,SE无显著变化(P>0.05,Scheffe检验)。高阶像差、彗差、球差和高阶散光术后增加,但术后1个月、6个月或4年随访期间像差无显著变化(37只眼)。与戴眼镜组相比,手术组生活质量总分显著更高(45.71±2.61对39.96±3.56;P<0.001)。
长期随访结果表明,SMILE为中高度近视提供了可预测且稳定的矫正效果。